Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001104659-22-111999

Options or other derivatives

  • Director acquired 362,318 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Juvenescence Ltd Director 2022-10-26 Grant or award · Warrant to Purchase Common Stock +362,318 362,318 D: show line 1 in the form
Loading xslF345X03/tm2229063-1_4seq1.xml…